{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:29:44Z","timestamp":1785925784652,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010798","name":"Sunway University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.sapharm.2025.06.108","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T06:41:47Z","timestamp":1751006507000},"page":"975-990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of pharmacist-led interventions in improving gout outcomes: A systematic review"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-7539","authenticated-orcid":false,"given":"Maria","family":"Tanveer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar Hussain","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-7120","authenticated-orcid":false,"given":"Sunil","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zawwad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-1853","authenticated-orcid":false,"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2025.06.108_bib1","doi-asserted-by":"crossref","DOI":"10.2196\/45943","article-title":"Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction","volume":"9","author":"He","year":"2023","journal-title":"JMIR Public Health and Surveillance"},{"issue":"11","key":"10.1016\/j.sapharm.2025.06.108_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10654-014-9927-y","article-title":"Determinants of the prevalence of gout in the general population: a systematic review and meta-regression","volume":"30","author":"Wijnands","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.sapharm.2025.06.108_bib4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"3s","key":"10.1016\/j.sapharm.2025.06.108_bib5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.semarthrit.2020.04.008","article-title":"Gout epidemiology and comorbidities","volume":"50","author":"Singh","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7861\/clinmedicine.17-1-54","article-title":"Gout - a guide for the general and acute physicians","volume":"17","author":"Abhishek","year":"2017","journal-title":"Clin Med (Lond)."},{"key":"10.1016\/j.sapharm.2025.06.108_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109977","article-title":"A review on gout: looking back and looking ahead","volume":"117","author":"Tao","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.sapharm.2025.06.108_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4081\/reumatismo.2011.238","article-title":"Clinical features of gout","volume":"63","author":"Grassi","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.sapharm.2025.06.108_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.sapharm.2025.06.108_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.sapharm.2025.06.108_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British society for rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.sapharm.2025.06.108_bib12","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10067-023-06578-9","article-title":"The Hong Kong society of rheumatology consensus recommendations for the management of gout","volume":"42","author":"Yip","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.sapharm.2025.06.108_bib13","article-title":"Management of gout following 2016\/2017 european (EULAR) and British (BSR) guidelines: an interrupted time-series analysis in the United Kingdom","volume":"18","author":"Russell","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.sapharm.2025.06.108_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.sapharm.2025.06.108_bib15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrrheum.2015.94","article-title":"Gout: why compare the effectiveness of suboptimal gout management?","volume":"11","author":"Dalbeth","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.sapharm.2025.06.108_bib16","article-title":"Comparative effectiveness of allopurinol and febuxostat in gout management","volume":"1","author":"O'Dell","year":"2022","journal-title":"NEJM Evidence"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13075-015-0752-9","article-title":"Erratum to: comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort","volume":"17","author":"Singh","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.sapharm.2025.06.108_bib18","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American college of physicians","volume":"166","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.sapharm.2025.06.108_bib19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"American college of rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.sapharm.2025.06.108_bib20","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"American college of rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.sapharm.2025.06.108_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","article-title":"Medication adherence among patients with gout: a systematic review and meta-analysis","volume":"47","author":"Scheepers","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ijpp\/riac025","article-title":"Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review","volume":"30","author":"Sinnappah","year":"2022","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2025.06.108_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40744-020-00249-w","article-title":"High rate of adherence to urate-lowering treatment in patients with gout: who's to blame?","volume":"7","author":"Perez-Ruiz","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.sapharm.2025.06.108_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3899\/jrheum.210950","article-title":"Why do patients with gout not take allopurinol?","volume":"49","author":"Emad","year":"2022","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/apc.2022.0192","article-title":"Pharmacist-involved antiretroviral stewardship programs in people living with HIV\/AIDS: a systematic review","volume":"37","author":"Ahmed","year":"2023","journal-title":"AIDS Patient Care STDS"},{"issue":"4S","key":"10.1016\/j.sapharm.2025.06.108_bib26","first-page":"S8","article-title":"Achievement of serum uric acid target by rheumatology clinic pharmacists compared with primary care providers in patients with gout","volume":"63","author":"Romano","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2025.06.108_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/20101058231152048","article-title":"Impact of pharmacist-led collaborative gout clinic on timely achievement of serum uric acid goals","volume":"32","author":"Cheong","year":"2023","journal-title":"Proc Singapore Healthc"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003627","article-title":"Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study","volume":"4","author":"Goldfien","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2018.11.011","article-title":"Adherence and outcomes with urate-lowering therapy: a site-randomized trial","volume":"132","author":"Mikuls","year":"2019","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.sapharm.2025.06.108_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1071\/HC18082","article-title":"Facilitating equitable prevention and management of gout for M\u0101ori in Northland, New Zealand, through a collaborative primary care approach","volume":"11","author":"Lawrence","year":"2019","journal-title":"J Prim Health Care"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7812\/TPP\/15-234","article-title":"Virtual gout management clinic for achieving target serum uric acid levels: a randomized clinical trial","volume":"20","author":"Goldfien","year":"2016","journal-title":"Perm J"},{"issue":"2","key":"10.1016\/j.sapharm.2025.06.108_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1715163518754916","article-title":"Pharmacists' assessment and management of acute and chronic gout","volume":"151","author":"Haines","year":"2018","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u210130.w4918","article-title":"Gout in primary care: can we improve patient outcomes?","volume":"6","author":"Callear","year":"2017","journal-title":"BMJ Qual Improv Rep"},{"issue":"5","key":"10.1016\/j.sapharm.2025.06.108_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.semarthrit.2016.10.006","article-title":"Pilot study of a multidisciplinary gout patient education and monitoring program","volume":"46","author":"Fields","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.sapharm.2025.06.108_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10067-019-04809-6","article-title":"eHealth-supported decentralized multi-disciplinary care for gout involving rheumatology, pharmacy, and dietetics: Proof-Of-Concept study","volume":"39","author":"Howren","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib36","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101051","article-title":"Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review","volume":"4","author":"Gill","year":"2020","journal-title":"BJGP Open"},{"issue":"12","key":"10.1016\/j.sapharm.2025.06.108_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1759720X18807117","article-title":"Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis","volume":"10","author":"Ramsubeik","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.sapharm.2025.06.108_bib38","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Cochrane","year":"2021"},{"issue":"7","key":"10.1016\/j.sapharm.2025.06.108_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.sapharm.2025.06.108_bib40","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.sapharm.2025.06.108_bib41","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"issue":"7-8","key":"10.1016\/j.sapharm.2025.06.108_bib42","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1345\/aph.1S006","article-title":"A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project","volume":"47","author":"Correr","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.sapharm.2025.06.108_bib43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00296-019-04333-5","article-title":"Pharmacist-managed titration of urate-lowering therapy to streamline gout management","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.sapharm.2025.06.108_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Systematic Reviews"},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"Updated european league against rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.japh.2019.11.016","article-title":"Pharmacist-led transitions-of-care services in primary care settings: opportunities, experiences, and challenges","volume":"60","author":"Slazak","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2025.06.108_bib47","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.sapharm.2021.07.020","article-title":"Effect of pharmacist care on clinical outcomes among people living with HIV\/AIDS: a systematic review and meta-analysis","volume":"18","author":"Ahmed","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.06.108_bib48","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.18549\/PharmPract.2020.3.2000","article-title":"Clinical pharmacists' interventions in the management of type 2 diabetes mellitus: a systematic review","volume":"18","author":"Pousinho","year":"2020","journal-title":"Pharm Pract (Granada)."},{"issue":"1","key":"10.1016\/j.sapharm.2025.06.108_bib49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12913-021-06897-0","article-title":"The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review","volume":"21","author":"Ahmed","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.1016\/j.sapharm.2025.06.108_bib50","first-page":"718","article-title":"Evolution of pharmacy practice and direct patient care roles for pharmacists in Bangladesh","volume":"4","author":"Hasan","year":"2021","journal-title":"JACCP: J American College Clin Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2025.06.108_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138492","article-title":"Changes in the prevalence of rheumatic diseases in shantou, China, in the past three decades: a COPCORD study","volume":"10","author":"Zeng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2025.06.108_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-017-3768-4","article-title":"Prevalence and incidence of gout in Korea: data from the national health claims database 2007\u20132015","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int"},{"issue":"17","key":"10.1016\/j.sapharm.2025.06.108_bib53","article-title":"Cost-effectiveness analysis of pharmacist adherence interventions in people living with HIV\/AIDS in Pakistan","volume":"11","author":"Ahmed","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"suppl l_3","key":"10.1016\/j.sapharm.2025.06.108_bib54","article-title":"O33 cana clinical pharmacist-led gout clinic help patients achieve target serum uric acid levels?","volume":"57","author":"Whiteman","year":"2018","journal-title":"Rheumatology"},{"issue":"suppl 9","key":"10.1016\/j.sapharm.2025.06.108_bib55","article-title":"Quality of gout management in a rheumatology clinic using a provider-pharmacist team-based approach\u00a0[abstract]","volume":"70","author":"Michaud","year":"2018","journal-title":"Arthritis Rheumatol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125003754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125003754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:26:45Z","timestamp":1762550805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1551741125003754"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.06.108","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of pharmacist-led interventions in improving gout outcomes: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.06.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}